BrainStorm Cell Therapeutics Inc. Deferring Shareholders Conference Call in Anticipation of Upcoming Developments

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (OTC.QB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced that it is deferring its shareholders conference call scheduled for December 11, 2012, in anticipation of significant positive company developments likely to be released shortly. The company will announce the re-scheduled conference call date as soon as senior management is authorized to discuss these developments.